why choose us

First received: June 27, 2023

Clinical Trial: A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Randomized, Double-Blind, Placebo-Contr

Brief Summary: The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight and have osteoarthritis (OA) of the knee.The study will lasts about 77 weeks.

Read more